Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Genexine, Inc. Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.	South Korea	095700
GENFLOW BIOSCIENCES PLC Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.	United Kingdom	GENF
GENINUS Inc. AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.	South Korea	389030
genOway Develops custom genetically modified preclinical models for biopharma and academic research.	France	ALGEN
Genpact LTD Drives business transformation for enterprises using AI, data, and technology services.	United States of America	G
GenSight Biologics S.A. Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.	France	SIGHT
GeoVax Labs, Inc. Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.	United States of America	GOVX
GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. A travel agency offering online booking for transport, hotels, cultural tours, and cruises.	Türkiye	GZNMI
GIG Works Inc. Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.	Japan	2375
Globe Capital Limited An investment company providing global marketing and promotion services, focusing on UK businesses.	Cayman Islands	GCAP